This video introduces "bridge recombinases," a novel and powerful genome editing method capable of performing large genomic insertions, deletions, and inversions. Building upon initial demonstrations in bacterial genomes, this technology has now been successfully adapted and optimized for use in human cells. The mechanism relies on an E. coli jumping gene, an enzyme that utilizes a "bridge RNA" with programmable loops to precisely target specific genomic locations and bind donor DNA. Through extensive screening and optimization of both the RNA (mutations, extensions, binding site swaps for enhanced specificity) and the enzyme, researchers achieved significant efficiency boosts. The method now boasts efficiencies up to 20% for insertions, 13% for deletions, and 10% for inversions, with the ability to invert sequences up to almost a megabase. An exciting application includes the programmable deletion of repeat sequences implicated in Friedreich's ataxia. While still requiring improvement in reducing off-target edits, bridge recombinases represent a significant advancement in precise, large-scale genome engineering.
Summarizing Bridge Recombinases: A New Tool for Large-Scale Genome Editing in Human Cells
0:00 Introduction to Bridge Recombinases: The video highlights "bridge recombinases" as a new and powerful method for making large (chunky) genome edits, including insertions, deletions, and inversions. This method has recently been successfully applied to human cells, following its initial demonstration in bacterial genomes.
0:20 Mechanism Overview: Bridge recombinases utilize an E. coli jumping gene (a DNA editing enzyme) that comes with its own RNA, termed "bridge RNA." This RNA contains two crucial loops: one to target a specific genomic location and another to bind donor DNA, effectively "bridging" the two DNA strands before combining them. Both loops are programmable.
0:44 Adaptation for Human Cells & Optimization: Researchers screened related jumping genes to find one with baseline activity in human cells. Significant optimization efforts included:
0:54 RNA Enhancement: A 4x efficiency boost was achieved by mutating and extending parts of the bridge RNA.
0:58 Enzyme Optimization: An additional 1.5x efficiency gain came from optimizing the enzyme itself.
1:03 Specificity Improvement: Swapping the target and donor binding locations on the RNA further boosted efficiency and specificity, as the payload binding loop proved better at encoding specificity.
1:13 Impressive Editing Statistics: The optimized method achieves high efficiencies:
1:21 Large Edits: The method can perform very large edits, demonstrating inversions of almost a megabase.
1:24 Promising Application: A notable application is the programmable deletion of repeat sequences that cause Friedreich's ataxia.
1:29 Current Limitation: A caveat of the current method is the presence of a fair number of off-target edits, indicating a key area for future improvement in "V2."